VeinCare Centers of Tennessee is one of the first clinics in the United States to implant the new BD Venovo stent in obstructed pelvic veins. The Venovo stent is the first stent designed specifically for use in treating obstruction of veins to be approved by the Food and Drug

  BiosupportMD is a nutraceutical company created by John Chuback, MD, FACS, RPVI, RVT, RPhS, and his business partners Christopher Tichio and Alexander von Summer in 2015. The company was the brainchild of Dr. Chuback, a board certified general and cardiovascular surgeon who has been specializing in the treatment of

  The U.S. Federal Drug Administration granted Aninger’s Pantheris SV small vessel image-guided atherectomy system pre-market approval in eight months. The Pantheris SV is an extension of the Redwood City, California-based company’s lumivascular image-guided atherectomy platform, which it hopes will expand the available market for its Pantheris devices by up

  Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins, effective April 8. Also effective April 8th, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All healthcare professionals will now be able

        SIGVARIS has changed its corporate name from SIGVARIS to SIGVARIS GROUP and has also changed its logo. SIGVARIS has a 150-year history of proven success, according to CEO Mark Bunker. “We are the world leader in medical compression socks and hosiery with a wide assortment of

  Merit Medical Systems Inc., a manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, announced Dec. 17 that it has acquired substantially all of the assets of Vascular Insights LLC, based in Quincy, Massachusetts. Vascular Insights’ primary assets are the ClariVein IC and ClariVein

  BTG plc highlighted the presentation of the two-year results for the SENTRY Trial at the Vascular Interventional Advances (VIVA) conference in Las Vegas. The prospective, multicenter trial of the BTG Sentry, the world’s first bioconvertible IVC filter, found that in addition to providing protection against pulmonary embolism (PE) during the

Amazon has teamed up with brand consultancy business Arcadia Group to launch a brand of consumer-use medical devices for diabetes and hypertension management, according  to a MedCity report. Called Choice, the new brand will initially include blood glucose monitors and blood pressure monitors accompanied by supporting mobile apps that offer measurement tracking, data mobility and

Fujifilm Medical Systems unveiled its FCT Embrace at the 2018 ASTRO annual meeting in October, marking Fujifilm’s entry into the U.S. CT market. The new system, combined with other market-leading oncology solutions, is designed to provide enhanced and efficient CT simulation with radiotherapy treatment planning capabilities. Approved by the FDA,